Literature DB >> 19499181

Disseminated toxoplasmosis in a patient with non-Hodgkin lymphoma.

M A Herold1, R Kühne, M Vosberg, S Ostheeren-Michaelis, P Vogt, U Karrer.   

Abstract

Toxoplasmosis is a well-recognized opportunistic disease in HIV-infected individuals that is caused by the reactivation of a previous infection, primarily in the central nervous system, during profound immunodeficiency. Toxoplasmosis has been described more rarely in patients with cancer and chemotherapy. We report a case of a patient with a history of chemotherapy for non-Hodgkin lymphoma who developed pain and progressive paresthesia of the right arm 6 weeks after remission. Relapsing lymphoma was suspected, and steroid and radiation treatment were initiated, but the patient died 5 days later due to multiple organ failure. Autopsy revealed disseminated toxoplasmosis. This case illustrates that toxoplasmosis should be suspected in patients with neoplastic disease, especially lymphomas, who present with unexplained neurologic, pulmonary, or febrile symptoms during or after chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19499181     DOI: 10.1007/s15010-009-9007-5

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  11 in total

1.  Detection of Toxoplasma gondii by polymerase chain reaction in cerebrospinal fluid from human immunodeficiency virus-1-infected Japanese patients with focal neurological signs.

Authors:  M Goto; T Takahashi; T Kanda; A Iwamoto
Journal:  J Int Med Res       Date:  2004 Nov-Dec       Impact factor: 1.671

2.  Cerebral toxoplasmosis in a patient with chronic lymphocytic leukaemia treated with fludarabine.

Authors:  S Bacchu; C Fegan; J Neal
Journal:  Br J Haematol       Date:  2007-09-04       Impact factor: 6.998

3.  Toxoplasmosis complicating malignancy. Experience at the National Cancer Institute.

Authors:  W M Vietzke; A H Gelderman; P M Grimley; M P Valsamis
Journal:  Cancer       Date:  1968-05       Impact factor: 6.860

4.  Toxoplasmosis. Clinical experiences in a cancer hospital.

Authors:  R M Carey; A C Kimball; D Armstrong; P H Lieberman
Journal:  Am J Med       Date:  1973-01       Impact factor: 4.965

5.  Toxoplasmosis in patients with cancer.

Authors:  D M Israelski; J S Remington
Journal:  Clin Infect Dis       Date:  1993-11       Impact factor: 9.079

Review 6.  Toxoplasmosis.

Authors:  J G Montoya; O Liesenfeld
Journal:  Lancet       Date:  2004-06-12       Impact factor: 79.321

7.  PCR assay using cerebrospinal fluid for diagnosis of cerebral toxoplasmosis in Brazilian AIDS patients.

Authors:  José E Vidal; Fabio Antonio Colombo; Augusto C Penalva de Oliveira; Roberto Focaccia; Vera Lucia Pereira-Chioccola
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

8.  Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome.

Authors:  F M Foss; D C Ihde; I R Linnoila; A B Fischmann; G P Schechter; J D Cotelingam; S M Steinberg; B C Ghosh; J L Stocker; A Bastian
Journal:  J Clin Oncol       Date:  1994-10       Impact factor: 44.544

9.  Acute toxoplasmosis in nonstem cell transplant patients with haematological malignancies: a study from a regional cancer institute in South India.

Authors:  S Adurthi; Tp Sahoo; Kumar Chakka; B Radhika; L Appaji; Pp Bapsy; C Ramesh; Rs Jayshree
Journal:  Hematol Oncol       Date:  2008-12       Impact factor: 5.271

10.  Detection of Toxoplasma gondii by PCR and tissue culture in cerebrospinal fluid and blood of human immunodeficiency virus-seropositive patients.

Authors:  M Dupon; J Cazenave; J L Pellegrin; J M Ragnaud; A Cheyrou; I Fischer; B Leng; J Y Lacut
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

View more
  6 in total

Review 1.  The occurrence and prevention of foodborne disease in vulnerable people.

Authors:  Barbara M Lund; Sarah J O'Brien
Journal:  Foodborne Pathog Dis       Date:  2011-05-11       Impact factor: 3.171

Review 2.  Disseminated toxoplasmosis in non-allografted patients with hematologic malignancies: report of two cases and literature review.

Authors:  S Scerra; H Coignard-Biehler; F Lanternier; F Suarez; C Charlier-Woerther; M-E Bougnoux; J Gilquin; M Lecuit; O Hermine; O Lortholary
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-18       Impact factor: 3.267

3.  Toxoplasma gondii infection in children with lymphoma in Eastern China: seroprevalence, risk factors and case-control studies.

Authors:  Yuhe Duan; Yunlai Zhi; Yusheng Liu; Na Zhou; Fujiang Li; Xiwei Hao; Xiangyan Zhang; Qian Dong; Lili Chen
Journal:  Epidemiol Infect       Date:  2019-11-26       Impact factor: 2.451

4.  Erdheim-Chester Disease Involving the Central Nervous System with Latent Toxoplasmosis.

Authors:  Tomoya Wadayama; Mikito Shimizu; Ikko Kimura; Kousuke Baba; Goichi Beck; Seiichi Nagano; Ryo Morita; Hidenori Nakagawa; Michinori Shirano; Tetsushi Goto; Kazumi Norose; Kenji Hikosaka; Shigeo Murayama; Hideki Mochizuki
Journal:  Intern Med       Date:  2022-02-08       Impact factor: 1.282

5.  Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries.

Authors:  Jaroslav Flegr; Joseph Prandota; Michaela Sovičková; Zafar H Israili
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

Review 6.  Acute exacerbation of pulmonary toxoplasmosis during corticosteroid therapy for immune thrombocytopenia: A case report and literature review.

Authors:  Koji Omori; Naoto Imoto; Kazumi Norose; Matsuyoshi Maeda; Kenji Hikosaka; Shingo Kurahashi
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.